Suppr超能文献

[儿童罕见病诊疗同质化管理专家建议]

[Expert recommendations on homogenization management of the diagnosis and treatment of rare diseases in children].

出版信息

Zhongguo Dang Dai Er Ke Za Zhi. 2023 Jul 15;25(7):663-671. doi: 10.7499/j.issn.1008-8830.2304036.

Abstract

Rare diseases in children are characterized by low prevalence, complex pathogenesis, variety, and difficulty in the diagnosis and treatment. With the development of medical services, progress has been made in the diagnosis and treatment of rare diseases. However, due to asymmetric allocation of medical resources at different levels, there are still many shortcomings in the establishment and promotion of the homogenized management system of rare disease diagnosis and treatment. In order to further standardize the homogenized management of rare diseases in children, achieve early and accurate diagnosis and treatment, and improve the quality of life of the children, the Rare Disease Diagnosis and Treatment Center of Tianjin Children's Hospital (Tianjin University Children's Hospital) invited relevant experts in the field to develop recommendations for the management model of homogenized diagnosis and treatment of rare diseases in children from the aspects of information construction, hierarchical diagnosis and treatment, personnel training, scientific popularization, and multi-participation. The recommendations provide reference for the regional homogenization of clinical diagnosis and treatment management system for children with rare diseases.

摘要

儿童罕见病具有患病率低、发病机制复杂、病种多样以及诊断和治疗困难等特点。随着医疗服务的发展,罕见病的诊断和治疗取得了进展。然而,由于不同层面医疗资源分配不均衡,在建立和推进罕见病诊疗同质化管理体系方面仍存在诸多不足。为进一步规范儿童罕见病的同质化管理,实现早期准确诊断和治疗,提高患儿生活质量,天津市儿童医院(天津大学儿童医院)罕见病诊疗中心邀请该领域相关专家,从信息建设、分级诊疗、人才培养、科普宣传及多方参与等方面,制定儿童罕见病同质化诊疗管理模式的建议。这些建议为儿童罕见病临床诊疗管理体系的区域同质化提供参考。

相似文献

6
9
[Healthcare for people with rare diseases: recommendations for successful intersectoral collaboration].[罕见病患者的医疗保健:成功开展跨部门合作的建议]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2023 Aug;66(8):940-948. doi: 10.1007/s00103-023-03719-y. Epub 2023 Jun 13.
10
Educational aspects of rare and orphan lung diseases.罕见和孤儿肺疾病的教育方面。
Respir Res. 2021 Mar 24;22(1):92. doi: 10.1186/s12931-021-01676-1.

本文引用的文献

2
[Early recognition, diagnosis and treatment of spinal muscular atrophy].
Zhonghua Er Ke Za Zhi. 2023 Mar 2;61(3):286-288. doi: 10.3760/cma.j.cn112140-20221116-00976.
3
[China guideline for pharmaceutical care on anti-tumor antibody-based drugs].《中国抗肿瘤抗体类药物药学服务指南》
Zhonghua Zhong Liu Za Zhi. 2022 Oct 23;44(10):1017-1046. doi: 10.3760/cma.j.cn112152-20220902-00593.
4
[Expert consensus on rehabilitation management of the spinal muscular atrophy].[脊髓性肌萎缩症康复管理专家共识]
Zhonghua Er Ke Za Zhi. 2022 Sep 2;60(9):883-887. doi: 10.3760/cma.j.cn112140-20220315-00201.
5
The Human Phenotype Ontology in 2021.2021 年人类表型本体论。
Nucleic Acids Res. 2021 Jan 8;49(D1):D1207-D1217. doi: 10.1093/nar/gkaa1043.
7
Orphan drug clinical development.孤儿药临床开发。
Therapie. 2020 Apr;75(2):141-147. doi: 10.1016/j.therap.2020.02.004. Epub 2020 Feb 13.
8
[A practice-based competencies training, certifying and evaluating system for genetic counseling in the United States].
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2019 Jan 10;36(1):37-43. doi: 10.3760/cma.j.issn.1003-9406.2019.01.007.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验